Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin-II antagonist and/or a diuretic
The invention relates to a pharmaceutical dosage form comprising an active ingredient combination of nifedipine or nisoldipine and at least one angiotensin-II antagonist and/or at least one diuretic, characterized in that nifedipine or nisoldipine are controlled (modified) in the body and the angiot...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
09.05.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to a pharmaceutical dosage form comprising an active ingredient combination of nifedipine or nisoldipine and at least one angiotensin-II antagonist and/or at least one diuretic, characterized in that nifedipine or nisoldipine are controlled (modified) in the body and the angiotensin-II antagonist and/or the diuretic is quickly released (immediate release (IR)), and to a method for production thereof, to the use thereof as a medicine and to the use thereof for prophylaxis, secondary prophylaxis or treatment of illnesses. |
---|---|
Bibliography: | Application Number: AU20090319362 |